Kanna
Psychoactive
Botanical

Kanna is a South African plant now sold in modern retail forms, including gummies, vapes, shots, capsules, and melts. It can affect mood, alertness, sleep, and mental state.

Kanna is being repackaged as modern mood, vape, gummy, and “party” products.

Kanna, also known as Sceletium tortuosum, is a plant native to South Africa. It has traditional use for mood and stress. Its active alkaloids include mesembrine and related compounds that can affect serotonin and other brain pathways.

Modern retail products are not the same as traditional use. Concentrated extracts, vapes, melts, shots, and combination products may contain unclear doses, added ingredients, and limited warnings about drug interactions or side effects.

It can look routine. Gummies, melts, shots, capsules, and disposable vapes may appear similar to ordinary wellness or novelty products.
It is widely available. Kanna products may be sold in gas stations, vape shops, smoke shops, CBD stores, convenience-style stores, and online marketplaces.
It hides behind natural claims. “Plant based,” “zero nicotine,” “zero THC,” and “dietary supplement” claims do not prove a product is safe.
Interactions matter. Because kanna can affect serotonin pathways, people taking antidepressants or other mood medications should avoid combining products without medical guidance.

Kanna, explained in plain English

Kanna is not just a harmless plant trend. It is a mood-altering botanical that may affect brain chemistry. Retail products can be concentrated, blended, or poorly labeled.

What is kanna?

Kanna is the common name for Sceletium tortuosum, a succulent plant native to South Africa. It has been traditionally chewed, brewed, smoked, or used as a snuff.

Today, companies sell kanna as gummies, vapes, shots, capsules, powders, and sublingual melts. These products may be marketed for mood, calm, sociability, focus, or a recreational effect.

Why should families and communities be concerned?

The concern is not traditional plant use. The concern is concentrated retail products sold with limited safety information, unclear dosing, and marketing that may suggest intoxication or a “legal high.”

  • Misleading forms: Gummies, melts, vapes, and shots can make a psychoactive product appear low-risk.
  • Unclear dosing: Milligram amounts do not always explain how strong the active alkaloids are.
  • Interaction risk: Kanna may interact with antidepressants, MAOIs, stimulants, MDMA, tramadol, St. John’s wort, and other serotonin-active substances.
  • Limited research: Most human studies are small, short-term, and often use standardized extracts, not retail vapes, gummies, or blended products.

Where is kanna sold?

Kanna products may be sold in gas stations, vape shops, smoke shops, CBD stores, convenience-style stores, head shops, and online. Products may appear near kratom, kava, phenibut, hemp-derived cannabinoids, mushroom blends, or other psychoactive botanicals.

Community members should look for “kanna,” “Sceletium tortuosum,” “sceletium,” “mesembrine,” or branded extracts such as “Zembrin.”

How is it marketed to look safe?

Kanna products often use natural, social, mood, wellness, or “zero” language that may make the product seem safer than it is.

  • “Zero nicotine” or “zero THC”
  • “Plant based”
  • “Dietary supplement”
  • “Mood support”
  • “Fast acting”
  • “Party enhancement” or “social ease”

“No nicotine” or “no THC” does not mean no psychoactive effect.

What are the effects and risks of kanna?

Reported effects may include mood elevation, relaxation, sociability, drowsiness, alertness, or changes in perception. Side effects reported in studies and safety reviews include headache, nausea, stomach upset, fatigue, drowsiness, difficulty concentrating, and trouble sleeping.

Higher-dose, recreational, inhaled, or blended products may carry additional risks that are not well studied.

Can kanna interact with medications?

Yes. Kanna contains compounds that may affect serotonin pathways. That matters because many medicines and drugs also affect serotonin.

People taking antidepressants, MAOIs, migraine medicines, tramadol, stimulant drugs, MDMA, St. John’s wort, or other mood-altering substances should not mix them with kanna without medical guidance. Warning signs of too much serotonin can include agitation, confusion, sweating, diarrhea, tremor, muscle stiffness, fever, fast heart rate, or seizures.

Is kanna legal?

Kanna is not federally scheduled as a controlled substance in the United States. However, legal availability does not mean a product has been reviewed for safety, purity, accurate labeling, or use in vapes and high-dose retail products.

Rules may vary by workplace, school, military policy, state law, and product contents.

What about kanna vapes?

Kanna vapes are a special concern because inhaling concentrated plant extracts is not the same as traditional use. The long-term effects of vaping kanna are not well studied.

Vape products may also contain solvents, flavors, cannabinoids, stimulants, or other ingredients that are not obvious from the front label.

What about melts, strips, and sublingual products?

Sublingual products dissolve in the mouth and may act faster than capsules. Faster onset can make it easier for someone to take more before they understand how the product affects them.

These products should not be treated as ordinary mints or wellness candies. They can contain concentrated psychoactive extracts.

Is kanna addictive?

Research on kanna dependence is limited. Some users report tolerance, cravings, mood changes, or feeling unwell after heavy use, but there is not enough high-quality evidence to describe a predictable withdrawal syndrome.

The safer message is simple: repeated use of any mood-altering product, especially one sold in concentrated or blended forms, can create risk.

What to look for in your neighborhood

Red flags on labels

  • Products labeled “Kanna,” “Sceletium,” “Sceletium tortuosum,” “mesembrine,” or “Zembrin.”
  • Gummies, melts, vapes, shots, capsules, powders, or strips promoted for mood, calm, sociability, focus, or party use.
  • Products that combine kanna with caffeine, kratom, kava, hemp-derived cannabinoids, mushrooms, or other psychoactive botanicals.
  • Disposable vape pens labeled “kanna,” “herbal,” “zero nicotine,” or “zero THC.”
  • Labels that do not clearly warn about antidepressants, MAOIs, serotonin-active drugs, or other interaction risks.
  • Products sold near kratom, kava, phenibut, blue lotus, hemp-derived cannabinoids, mushroom blends, or other psychoactive botanicals.

What communities can do

  • Take clear photos of the front label, ingredient panel, warnings, lot number, and shelf display.
  • Warn schools, parent groups, prevention coalitions, recovery groups, and community organizations about kanna vapes, gummies, shots, and melts.
  • For immediate symptoms or accidental exposure, call Poison Control at 1-800-222-1222.
  • Report deceptive marketing to the FTC: reportfraud.ftc.gov
  • Report serious adverse events to FDA MedWatch and share concerns with local health departments.
  • Ask local and state officials to review labeling, retail sale, product testing, and enforcement gaps.
Download Community Alert Report a Product